Pfizer’s CRO plans for Sandwich will have limited impact
March 15, 2011Business Services, Research and Development Jobs, Kent, Pfizer, Sandwich, job cuts
Pfizer’s efforts to attract contract research organisations to take over part of its Sandwich research site will only benefit a …
CO2 could simplify pharma processing, say US chemists
March 15, 2011C02, carbon dioxide, manufacturing techniques, pharma manufacturing
Carbon dioxide could hold the key to a quicker, easier and greener method for manufacturing a range of commonly-used pharmaceuticals, …
J&J charged with US manufacturing violations
March 15, 2011Manufacturing and Production J&J, JJ, Johnson and Johnson, McNeil Consumer Healthcare, McNeil Fort Washington, McNeil recall, Motrin recall, manufacturing compliance, pharma manufacturing, recalls
Johnson & Johnson subsidiary McNeil Consumer Healthcare has been officially charged with manufacturing and distributing drugs in violation of federal …
Daiichi recalls contaminated paediatric vaccines
March 15, 2011Manufacturing and Production ActHIB, Daiichi Sankyo, manufacturing compliance, padiatric vaccine recall, recalls, vaccines
Japanese drugmaker Daiichi Sankyo has recalled around 1.3 million doses of the paediatric vaccine ActHIB, manufactured by Sanofi-Aventis, because of …
Lib Dems push for major amendments in Health Bill
March 14, 2011Dr Even Harris, Health and Social Care Bill, Liberal Democrat health policy, NHS, NHS reforms
Liberal Democrats activists have rejected the government’s NHS reform programme, voting overwhelmingly in favour of a major amendment to the …
Bayer-helmed oncology biomarker project launched
March 14, 2011Manufacturing and Production, Research and Development AstraZeneca, Bayer, Janssen, Max Planck Institute, Merck, OncoTrack, Pfizer, Roche, biomarkers, oncology
A project to develop the next generation of oncology biomarkers has been launched in Berlin. The pharma industry and European …
Pfizer sells Irish manufacturing facility to Amgen
March 14, 2011Manufacturing and Production Amgen, Dun Laoghaire, Ireland, Pfizer, pharma manufacturing, pharma manufacturing in Ireland
Amgen has come to the rescue of 280 workers whose jobs were threatened by the closure of a manufacturing facility …
Diabetes trial disappointment for GSK and Tolerx
March 14, 2011Research and Development DEFEND-1, DEFEND-2, GSK, GlaxoSmithKline, Tolerx, diabetes, otelixizumab, type I diabetes
GSK and Tolerx’s type I diabetes drug otelixizumab has failed to meet its primary endpoint in a late-stage trial. Anti-CD3 …
Anticipating the competition in pharma
March 14, 2011Sales and Marketing business intelligence, competitor intelligence, market research
Sun Tzu, the ancient Chinese military strategist wrote: “Conquerors estimate before the war begins, and they consider everything; the defeated …
NICE rejects PharmaMar’s ovarian cancer drug Yondelis
March 14, 2011Sales and Marketing Cancer, NICE, PharmaMar, Trabectedin, Yondelis, ovarian cancer
NICE has rejected PharmaMar’s ovarian cancer drug in final draft guidance due to a lack of ‘robust’ data. Yondelis (trabectedin) …
Former Gates Foundation director joins Sanofi
March 14, 2011Research and Development Dr Richard Klausner, Sanofi-Aventis, appointment, research and development
Sanofi-Aventis has appointed a former Gates Foundation director to chair its strategic development and scientific advisory council. Dr Richard Klausner …
Perry Evans to lead RSA Interims
March 11, 2011Business Services, Sales and Marketing Perry Evens, RSA Interims, appointment, business services, rsa, sales and marketing
UK-based life science search company RSA has appointed Perry Evans director of RSA Interims. He joined the company in 2006 …
Sanofi lung cancer drug fails in late-stage trial
March 11, 2011Research and Development Cancer, NSCLC, Regeneron, Sanofi-Aventis, aflibercept, non-small cell lung cancer
Sanofi-Aventis’ lung cancer drug aflibercept has failed to meet its primary endpoint in a phase III trial. The late-stage VITAL …
UK dementia awareness campaign launched
March 11, 2011Medical Communications dementia, disease awareness, disease awareness campaigns, stroke
The Department of Health has launched a £1.2 million awareness campaign which aims to alert people to the early signs …
Tangles and plaques: unlocking the secrets of Alzheimer’s disease
March 11, 2011Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, bapineuzumab, dimebon, latrepirdine, solanezumab
Despite many years of relentless research efforts, Alzheimer’s disease, the most common form of dementia, remains impossible to cure. According …
US approval for GSK’s lupus treatment Benlysta
March 10, 2011Sales and Marketing Benlysta, GSK, GlaxoSmithKline, Human Genome Sciences, Lupus, belimumab, systemic lupus erythematosus
GlaxoSmithKline’s lupus treatment Benylsta has won an historic approval in the US, but will have to prove its safety record …
Matthew Kent moves to 90TEN Healthcare
March 10, 2011Medical Communications 90Ten Healthcare, Matthew Kent, appointment, medical communications
90TEN Healthcare has appointed Matthew Kent as an associate director and to its senior management team. He joins the company …
New skills and ways of working in healthcare comms
March 10, 2011Medical Communications HCA, Healthcare Communications Association, benchmarking
A new report from the Healthcare Communications Association (HCA) indicates a trend towards new skills and ways of working, as …
Novartis’ COPD drug recommended for FDA approval
March 10, 2011Sales and Marketing Arcapta Neohaler, COPD, Novartis, Onbrez Breezhaler, QAB143, chronic obstructive pulmonary disease, indacterol
Novartis has won the backing of an FDA advisory committee for its chronic obstructive pulmonary disease (COPD) treatment QAB149. The …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
